TH34658A - The use of GLP-1 or a similar agent to suspend catabolic transformation after dissection. - Google Patents
The use of GLP-1 or a similar agent to suspend catabolic transformation after dissection.Info
- Publication number
- TH34658A TH34658A TH9701003443A TH9701003443A TH34658A TH 34658 A TH34658 A TH 34658A TH 9701003443 A TH9701003443 A TH 9701003443A TH 9701003443 A TH9701003443 A TH 9701003443A TH 34658 A TH34658 A TH 34658A
- Authority
- TH
- Thailand
- Prior art keywords
- glp
- catabolic
- dissection
- suspend
- transformation
- Prior art date
Links
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title claims abstract 10
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title claims abstract 4
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title claims abstract 4
- 230000001925 catabolic effect Effects 0.000 title claims abstract 4
- 238000002224 dissection Methods 0.000 title claims 2
- 230000009466 transformation Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 4
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 230000003054 hormonal effect Effects 0.000 abstract 2
- 238000010606 normalization Methods 0.000 abstract 2
- 230000002980 postoperative effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
Abstract
DC60 (03/10/40) การประดิษฐ์นี้ให้วิธีการบรรเทาการเปลี่ยนแปลงคะตะโบลิกและการตอบสนองทางฮอร์โมนต่อ ความเครียดภายหลังการผ่าตัด GLP-1, GLP-1 อะนาลอก, และอนุพันธ์ GLP-1 ถูกให้ที่ปริมาณที่ให้ผล ใน การทำให้ระดับกลูโคสในโลหิตเป็นปกติ การประดิษฐ์นี้ให้วิธีการบรรเทาการเปลี่ยนแปลงคะตะโบลิกและการตอบสนองทางฮอร์โมนต่อความเครียดภายหลังการผ่าตัด GLP-1, GLP-1 อะนาลอกและอนุพันธ์ GLP-1 ถูกให้ที่ปริมาณที่ให้ผลใน การทำให้ระดับกลูโคสในโลหิตเป็นปกติ สิทธิบัตรยา DC60 (03/10/40) This invention provides a means to mitigate catabolic alteration and hormonal responses to Postoperative stress GLP-1, GLP-1 analogs, and GLP-1 derivatives were administered at doses that resulted in the normalization of blood glucose levels. The invention provides a method for mitigating catabolic alteration and hormonal responses to postoperative stress. GLP-1, GLP-1 analogs and GLP-1 derivatives were administered at effective doses in Normalization of blood glucose levels, patent medicine
Claims (5)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH34658A true TH34658A (en) | 1999-08-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002318211A1 (en) | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
| KR950031069A (en) | How to suppress bone loss and lower serum cholesterol | |
| WO2003004031A1 (en) | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
| MXPA03006217A (en) | Spaced drug delivery system. | |
| WO2001032158A3 (en) | Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent | |
| EA200000468A1 (en) | THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY | |
| WO2002065985A3 (en) | Methods of treating diabetes mellitus | |
| Oldfield 3rd et al. | Randomized, double-blind trial of 1-versus 4-hour amphotericin B infusion durations | |
| BR0013540A (en) | Pharmaceutical formulations and their use in preventing stroke, diabetes and / or congestive heart failure. | |
| CA2344144A1 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
| WO2004050025A3 (en) | Combination of ibuprofen and oxycodone for acute pain relief | |
| KR970032872A (en) | Drugs for the treatment of skin damage containing acetylsalicylic acid | |
| KR960003729A (en) | Drugs with antihyperglycemic action | |
| WO2005020959A3 (en) | Novel drug compositions and dosage forms of topiramate | |
| EP1393738A4 (en) | ANTIDIABETIC TREATMENT | |
| CA2166704C (en) | Arsenic medicaments for the treatment of chronic fatigue syndrome | |
| RU99119233A (en) | PHARMACEUTICAL COMPOSITIONS containing ibuprofen and domperidone for the treatment of migraine | |
| RU2007133435A (en) | METHOD OF COMBINED TREATMENT AND APPLICABLE FOR THIS COMBINATION OF MEDICINES | |
| TH34658A (en) | The use of GLP-1 or a similar agent to suspend catabolic transformation after dissection. | |
| RU96115219A (en) | METHOD FOR TREATING PATIENTS WITH SUGAR DIABETES | |
| WO2000066550A8 (en) | New compounds | |
| NO982988L (en) | Remedy for prophylaxis and treatment of diabetic complications | |
| EP0256856A3 (en) | A parenterally administrable composition | |
| AR013352A1 (en) | USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION. | |
| BRPI0415322A (en) | antiretroviral pharmaceutical composition, process for the preparation of an antiretroviral pharmaceutical composition, method for reducing the burden of pill consumption for a patient, method for increasing lamivudine and zidovudine half-life while not affecting nevirapine half-life |